Men presenting for radical prostatectomy on preoperative statin therapy have reduced serum prostate specific antigen

The Journal of Urology
L Spencer KranePiyush K Agarwal

Abstract

Studies have suggested that statin (3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors) medication use may decrease prostate specific antigen in healthy men. We determined the effect of preoperative statin use on total preoperative prostate specific antigen and the risk of biochemical recurrence in patients with prostate cancer presenting for radical prostatectomy. A retrospective review of 3,828 patients undergoing radical prostatectomy from January 2001 to July 2008 at our institution identified 1,031 on statin medications. We compared these 1,031 patients to the remaining 2,797 not on statins preoperatively. We evaluated differences in prostate specific antigen overall, and when patients were stratified by age specific groups, body mass index and Gleason grades on final pathology. We also investigated differences in biochemical recurrence rates. Overall median serum prostate specific antigen was lower in patients on preoperative statins (5.0 vs 5.2 ng/ml, p = 0.002). Median prostate specific antigen was lower in men on statins with Gleason grades 7 or 8/9 disease (p <0.05). Using a multivariate logistic regression model statin therapy was associated with a 4.7% decrease in prostate specific antigen (p <0.001). Stati...Continue Reading

References

Aug 12, 1999·The New England Journal of Medicine·R H Knopp
Dec 23, 2003·Journal of Cellular Biochemistry·Michael R Freeman, Keith R Solomon
Mar 10, 2004·The New England Journal of Medicine·Christopher P CannonUNKNOWN Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators
Aug 13, 2004·The New England Journal of Medicine·Pim van der HarstDirk J van Veldhuisen
Jul 15, 2005·American Journal of Epidemiology·Jackilen ShannonPaige E Farris
Jan 5, 2006·JAMA : the Journal of the American Medical Association·Krista M DaleC Michael White
Oct 7, 2006·American Journal of Epidemiology·David M WernyEdward W Gregg
Nov 30, 2006·International Journal of Cancer. Journal International Du Cancer·Danielle R L Browning, Richard M Martin
Dec 21, 2006·Journal of the National Cancer Institute·Elizabeth A PlatzEdward Giovannucci
Aug 9, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Susan A HallJohn B McKinlay
Oct 19, 2007·Pharmacoepidemiology and Drug Safety·Gary D FriedmanLaurel A Habel
Nov 1, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Eric J JacobsEugenia E Calle
Nov 1, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·E Dawn FlickBette J Caan
Nov 17, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Teemu J MurtolaAnssi Auvinen
Nov 22, 2007·JAMA : the Journal of the American Medical Association·Lionel L BañezStephen J Freedland
Jan 15, 2008·Lancet·UNKNOWN Cholesterol Treatment Trialists' (CTT) CollaboratorsC Baigent
Mar 7, 2008·Cancer Causes & Control : CCC·Denise M BoudreauDiana L Miglioretti
Apr 3, 2008·Current Opinion in Urology·Robert J Hamilton, Stephen J Freedland
Oct 30, 2008·Journal of the National Cancer Institute·Robert J HamiltonStephen J Freedland

❮ Previous
Next ❯

Citations

Dec 4, 2012·The British Journal of Nutrition·Mohammad Reza SafarinejadShiva Safarinejad
Sep 4, 2013·Prostate Cancer and Prostatic Diseases·M RiekenS F Shariat
Mar 20, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H S ParkL A Mucci
Mar 29, 2014·Lipids in Health and Disease·Jenny Hanbi KimKishor M Wasan
Apr 10, 2010·Expert Opinion on Drug Safety·Denise M BoudreauJeanene Johnson
Apr 21, 2012·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·V MisraiP Grosclaude
May 17, 2011·The Journal of Urology·Nelly TanJ Stephen Jones
Dec 23, 2015·The Prostate·Teemu KeskiväliTeemu J Murtola
Apr 2, 2011·BJU International·Chad R RitchJames M McKiernan
Jan 25, 2012·International Journal of Radiation Oncology, Biology, Physics·Moein AlizadehDaniel Taussky
Mar 1, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Georgios PapadopoulosTheodoros Kassimatis
Apr 28, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anthony V D'Amico
Jul 22, 2016·Nutrition and Metabolic Insights·Melissa A BabcookSanjay Gupta
Feb 9, 2018·Oncotarget·Alfredo Caro-MaldonadoArkaitz Carracedo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.